Overview
Portfolio
More
AME Cloud Ventures
Palo Alto, United States
AME Cloud Ventures invests in seed to later‑stage companies that build infrastructure and value chains around data. They focus on technology‑heavy founders creating unique data assets across the stack—from hardware senso...
Portfolio
15+
Employees
5+
Founded
2012
AUM
≈ $0.0
Investment focus
Stages
Seed → Series C+
Industries
Artificial IntelligenceBiotechnologyEnterprise SoftwareHealthcare Technology
Geographic scope
Global
Sources
AME Cloud Ventures
AME Cloud Ventures invests in seed to later‑stage companies that build infrastructure and value chains around data. They focus on technology‑heavy founders creating unique data assets across the stack—from hardware sensors to AI‑driven applications—supporting them with operational expertise and global networks.
Portfolio
15+
Employees
5+
Founded
2012
AUM
≈ $0.0
Stages
Seed → Series C+
Industries
Artificial IntelligenceBiotechnologyEnterprise SoftwareHealthcare TechnologyQuantum Computing
Geographic scope
Global
Sources
Showing 10 of 10 matched portfolio companies
Capella Space operates a constellation of Synthetic Aperture Radar (SAR) satellites that provide high-resolution imagery and near real-time data, enabling 24/7 monitoring of the Earth regardless of weather conditions. This technology supports critical applications such as disaster response, environmental monitoring, and security assessments by delivering actionable insights for informed decision-making.
Funding: $344.0M
Rough estimate of the amount of funding raised
Funding: $344.0M
Rough estimate of the amount of funding raised
EdgeQ develops a Base Station-on-a-Chip that integrates 4G and 5G technologies for small and macro cell deployments, enabling customizable and field-deployable solutions compliant with 3GPP standards. This technology addresses the need for efficient, low-power wireless infrastructure to enhance network coverage and support mission-critical applications in various environments.
Funding: $113.5M
Rough estimate of the amount of funding raised
Funding: $113.5M
Rough estimate of the amount of funding raised
Pioneers precision immunology by developing patient-specific therapies that prioritize individual biological responses over traditional molecule-first approaches. This method addresses the limitations of generic treatments for immune-mediated diseases, aiming to deliver more effective and personalized therapeutic options.
Funding: $64.0M
Rough estimate of the amount of funding raised
Funding: $64.0M
Rough estimate of the amount of funding raised
Freenome provides a blood‑based early cancer detection platform that uses multiomics profiling—integrating genomics, epigenomics, proteomics, and metabolomics—with AI‑driven analysis to identify cancer at its most treatable stages. The minimally invasive test is designed for routine screening across multiple cancer types and is validated through ongoing clinical programs for use by healthcare providers.
Funding: $50.0M
Rough estimate of the amount of funding raised
Funding: $50.0M
Rough estimate of the amount of funding raised
Geopipe creates immersive digital twins of real-world environments using machine learning to process raw sensor data, such as photos and laser scans. This technology enables game developers, architects, and VR artists to rapidly construct realistic simulations and experiences without extensive modeling efforts.
Funding: $4.5M
Rough estimate of the amount of funding raised
Funding: $4.5M
Rough estimate of the amount of funding raised
Rigetti Computing develops full-stack quantum systems utilizing superconducting qubits, specifically their 9-qubit quantum processing unit (QPU), which is designed for immediate deployment. This technology enables researchers to perform complex computations at unprecedented speeds, addressing the limitations of classical computing in solving intricate problems.
Funding: $872.0M
Rough estimate of the amount of funding raised
Funding: $872.0M
Rough estimate of the amount of funding raised
The startup provides a cloud platform that standardizes data definitions across multi-cloud environments and identifies duplicate data pipelines for review. This enables cross-functional teams to efficiently manage, discover, and utilize metrics and machine learning features through a unified web portal.
Funding: $4.0M
Rough estimate of the amount of funding raised
Funding: $4.0M
Rough estimate of the amount of funding raised
Spect provides a portable retinal camera and a telemedicine platform that enables healthcare providers to conduct diabetic retinopathy screenings and other retinal exams in under three minutes, using existing medical staff. This solution addresses the critical shortage of eye specialists and the low rates of annual eye exams among diabetic patients, facilitating early detection of preventable vision loss.
Funding: $5.1M
Rough estimate of the amount of funding raised
Funding: $5.1M
Rough estimate of the amount of funding raised
Synthego provides chemically synthesized guide RNAs, GMP‑grade Cas nucleases, and related molecular biology reagents for genome‑editing research and therapeutic development. Their custom manufacturing and regulatory‑compliant services enable academic labs and biotech companies to obtain consistent, scalable components for discovery and IND‑ready applications.
Vicarious Surgical develops a robotic system that enables surgeons to perform minimally invasive abdominal surgery through a single 1.5 cm incision, enhancing visibility and instrument maneuverability with human-inspired motion. This technology reduces the risk of complications and shortens recovery times by minimizing tissue damage compared to traditional surgical methods.
Funding: $45.0M
Rough estimate of the amount of funding raised
Funding: $45.0M
Rough estimate of the amount of funding raised
Showing 5 of 5 unmatched portfolio companies